Entity Name: | NALPROPION PHARMACEUTICALS, INC. |
Jurisdiction: | FLORIDA |
Filing Type: | Foreign Profit |
Status: |
Inactive
The business entity is inactive. This status may signal operational issues or voluntary closure, raising concerns about the business's ability to repay loans and requiring careful risk assessment by lenders. |
Date Filed: | 19 Feb 2019 (6 years ago) |
Date of dissolution: | 26 Nov 2019 (5 years ago) |
Last Event: | WITHDRAWAL |
Event Date Filed: | 26 Nov 2019 (5 years ago) |
Document Number: | F19000000872 |
FEI/EIN Number |
825338324
Federal Employer Identification (FEI) Number assigned by the IRS. |
Address: | 9171 TOWNE CENTRE DR, STE. 270, SAN DIEGO, CA, 92122, US |
Mail Address: | 9171 TOWNE CENTRE DR, STE. 270, SAN DIEGO, CA, 92122, US |
Place of Formation: | DELAWARE |
Name | Role | Address |
---|---|---|
FORBES MONICA | Vice President | 9171 TOWNE CENTRE DR, STE. 270, SAN DIEGO, CA, 92122 |
HANSON KRIS | Vice President | 9171 TOWNE CENTRE DR, STE. 270, SAN DIEGO, CA, 92122 |
MERCER JACOB | Director | 9171 TOWNE CENTRE DR, STE. 270, SAN DIEGO, CA, 92122 |
SEGAL JONATHAN | Director | 9171 TOWNE CENTRE DR, STE. 270, SAN DIEGO, CA, 92122 |
CORPORATION SERVICE COMPANY | Agent | - |
Event Type | Filed Date | Value | Description |
---|---|---|---|
WITHDRAWAL | 2019-11-26 | - | - |
Name | Date |
---|---|
Withdrawal | 2019-11-26 |
Foreign Profit | 2019-02-19 |
Date of last update: 01 Mar 2025
Sources: Florida Department of State